This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Lecithin is fatty substances commonly found in nutritional supplements.
- Generic Name
- Lecithin
- DrugBank Accession Number
- DB15834
- Background
A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols.
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Lecithins
- Phosphatidylcholine
- Phospholutein
- External IDs
- LT-02
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image MENAPHASE FORMULA FILM TABLET, 90 ADET Lecithin (18 mg) + Ascorbic acid (42 mg) + Biotin (0.05 mg) + Calcium (167 mg) + Choline (3.1 mg) + Chromium (0.0217 mg) + Copper (0.33 mg) + Cyanocobalamin (0.0083 mg) + Ferrous gluconate (3 mg) + Folic acid (0.067 mg) + Inositol (3.1 mg) + Iodine (0.0025 mg) + Magnesium oxide (84 mg) + Manganese (0.6 mg) + Molybdenum (0.0083 mg) + Niacin (8.3 mg) + Calcium pantothenate (8.3 mg) + Phosphorus (35 mg) + Potassium citrate (8.3 mg) + Pyridoxine (16.7 mg) + Riboflavin (8.5 mg) + Selenium (0.0117 mg) + Thiamine (7.5 mg) + Vitamin A (833 IU) + Vitamin D (67 IU) + Vitamin E (67 IU) + Zinc (2.5 mg) Tablet Oral FERROSAN SAĞLIK ÜRÜN VE HİZMETLERİ A.Ş. 1996-10-10 Not applicable Turkey 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- 8002-43-5
References
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Completed Treatment Acute Liver Injury, Drug Induced 1 4 Unknown Status Treatment Chronic Hepatitis B Infection 1 3 Completed Treatment Hepatic and Hepatobiliary Disorders 1 3 Completed Treatment Ulcerative Colitis 1 3 Recruiting Treatment Acute Liver Injury, Drug Induced 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule, gelatin coated Oral Gel Topical Capsule Oral 1200 mg Capsule, gelatin coated Oral Capsule Oral Capsule Oral 420 mg Capsule, liquid filled Oral Tablet Oral Capsule Oral Capsule Oral 1000 MG - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 14, 2020 21:52 / Updated at July 03, 2021 01:49